SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ray NF, Chan JK, Thamer M, Melton LJ 1997 Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. J Bone Miner Res 12:2435.
  • 2
    Dawson-Hughes B, Dallai GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S 1990 A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 323:878883.
  • 3
    Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, Kendler DL, Lentle B, Olszynski W, Ste.-Marie L-G, Tenenhouse A, Chines AA 1997 Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 337:382387.
  • 4
    Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice M-P, Czachur M, Diafotis AG 1998 Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 339:292299.
  • 5
    Cohen S, Levy RM, Keller M, Boling E, Emkey RD, Greenwald M, Zizic TM, Wallach S, Sewell KL, Lukert BP, Axelrod DW, Chines AA 1999 Risedronate therapy prevents corticosteroid-induced bone loss. Arthritis Rheum 42:23092318.
  • 6
    Mussolino ME, Looker AC, Madans JH, Langlois JA, Orwoll ES 1998 Risk factors for hip fracture in white men: The NHANES I epidemiologic follow-up study. J Bone Miner Res 13:918924.
  • 7
    Nguyen T, Sambrook P, Kelly P, Jones G, Lord S, Freund J 1993 Prediction of osteoporotic fractures by postural instability and bone density. BMJ 307:11111115.
  • 8
    De Laet CEDH, Van Hout BA, Burger H, Weel AEAM, Hofman A, Pols HAP 1998 Hip fracture prediction in elderly men and women: Validation of the Rotterdam Study. J Bone Miner Res 13:15871593.
  • 9
    O'Neill TW, Varlow J, Silman AJ, Reeve J, Reid DM, Todd C, Woolf AD 1994 Age and sex influences on fall characteristics. Ann Rheum Dis 53:773775.
  • 10
    Gilsanz V, Boechat MI, Gilsanz R, Loro ML, Roe TF, Goodman WG 1994 Gender differences in vertebral sizes in adults: Biomechanical implications. Radiology 190:678682.
  • 11
    Seeman E 1997 From density to structure: Growing up and growing old on the surfaces of bone. J Bone Miner Res 12:509521.
  • 12
    Seeman E 1999 Osteoporosis in men. Osteoporos Int 9 (Suppl 2):S97S110.
  • 13
    Greenspan SL, Myers ER, Maitland LA, Kido TH, Krasnow MB, Hayes WC 1994 Trochanteric bone mineral density is associated with type of hip fracture in the elderly. J Bone Miner Res 9:18891894.
  • 14
    Kroger H, Lunt M, Reeve J, Dequeker J, Adams JE, Birkenhager JC, Diaz Curiel M, Felsenberg D, Hyldstrup L, Kotzki P, Laval-Jeantet A-M, Lips P, Louis O, Perez Cano R, Reiners C, Ribot C, Ruegsegger P, Schneider P, Braillon P, Pearson J 1999 Bone density reduction in various measurement sites in men and women with osteoporotic fractures of spine and hip: The European quantitation of osteoporosis study. Calcif Tissue Int 64:191199.
  • 15
    Ross PD, Lombardi A, Freedholm D, 1999 The assessment of bone mass in men. In: OrwollES (ed.) Osteoporosis in Men: The Effects of Gender on Skeletal Health. Academic Press, San Diego, CA, U.S.A., pp. 505525.
  • 16
    Cheng S, Suominen H, Sakari-Rantala R, Laukkanen P, Avikainen V, Heikkinen E 1997 Calcaneal bone mineral density predicts fracture occurrence: A five-year follow-up study in elderly people. J Bone Miner Res 12:10751082.
  • 17
    De Lait CEDH, van Hout BA, Burger H, Hofman A, Pols HAP 1997 Bone density and risk of hip fracture in men and women: Cross sectional analysis. BMJ 315:221225.
  • 18
    Melton LJ, Atkinson EJ, O'Connor MK, O'Fallon WM, Riggs BL 1998 Bone density and fracture risk in men. J Bone Miner Res 13:19151923.
  • 19
    Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P 1999 Alendronate treatment of osteoporosis in men. J Bone Miner Res 14:S184.
  • 20
    Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR 1999 Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. JAMA 282:637645.
  • 21
    Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, Palermo L, Prineas R, Rubin SM, Scott JC, Vogt T, Wallace R, Yates AJ, LaCroix AZ 1998 Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. JAMA 280:20772082.
  • 22
    Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE 1996 Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:15351541.
  • 23
    Looker AC, Orwoll ES, Johnston CC, Lindsay RL, Heinz WW, Dunn WL, Calvo MS, Harris TB, Heyse SP 1997 Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 12:17611768.
  • 24
    Melton LJ 1997 Editorial: The prevalence of osteoporosis. J Bone Miner Res 12:17691771.
  • 25
    Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN 1996 Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol 144:258261.